Who owns CONTEXT THERAPEUTICS INC COM?
- Ticker: CNTX
- CUSIP Number: 21077p108
Tip: Access positions for across all investors
Analyze quarterly positions in Context Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Context Therapeutics stock
Who bought or sold CONTEXT THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Opaleye Management | 975k | $1.1M | 100% | Dec 2023 |
|
| Vanguard Group | 596k | $674k | 0% | Dec 2023 |
|
| HighTower Advisors | 126k | $142k | 0% | Dec 2023 |
|
| Clear Harbor Asset Management | 36k | $41k | 0% | Dec 2023 |
|
| Sheets Smith Wealth Management | 20k | $23k | 0% | Dec 2023 |
|
| Citadel Advisors | 16k | $18k | 52% | Dec 2023 |
|
| UBS Group | 9.5k | $11k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 1.5k | $1.7k | 0% | Dec 2023 |
|
| Retirement Group | 155.00 | $213.993000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 114.00 | $129.002400 | 6% | Dec 2023 |
|
| Bank of America Corporation | 109.00 | $121.109900 | 9% | Dec 2023 |
|
| Jpmorgan Chase & Co | 23.00 | $25.999200 | 44% | Dec 2023 |
|
Who sold out of Context Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aspire Wealth Management Corp | Dec 2023 | 10k | $11k |